MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202418029476 A) filed by Immunogen Inc. on April 11, 2024, for Anti-Folr1 Immunoconjugate Dosing Regimens.
Inventors include Running, Kelli; Mastico, Robert A.; O'Leary, James J.; Ab, Olga; and Wolf, Beni B. Filed On.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: Methods of administering immunoconjugates that bind to FOLR1 are provided. The methods comprise administering an anti-FOLR1 immunoconjugate to a person in need thereof, for example, a cancer patient, at a therapeutically effective dosing regimen that results in minimal adverse effects.
Disclaimer: Curated by HT Syndication....